Page 5 - Project Baseline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Amy Abernethy, FDA veteran, joins Verily as tech firm plots next steps.

Healthcare

(Photo credit: Getty Images/Westend61) Over the last year, digital has transformed the caregiver experience, but pharma has also been undergoing a metamorphosis in order to reach patients. During the pandemic, life science companies were pushed to reconfigure their care in order to meet the needs of some of the most at-risk patients. MobiHealthNews sat down with the leader of pharma giant Otsuka's Global Clinical Development on Nephrology, Dr. Charlotte Jones-Burton, to talk about innovating for rare disease, digital in clinical trials and lessons learned from past tech partnerships. One ...

MedCity News Otsuka launches pivotal trial of digital therapeutics for depression Otsuka Pharmaceutical is partnering with Click Therapeutics to launch a remote clinical trial to evaluate the effectiveness of digital therapeutics in reducing depressive symptoms. Shares0 Otsuka Pharmaceutical is launching a virtual study to see if digital therapeutics can reduce depression symptoms. It’s the next step in a partnership between the Tokyo-based drugmaker and Click Therapeutics, a digital health startup that is developing programs for smoking cessation, depression and insomnia. They plan to en...

Daiichi Sankyo, Clover Biopharmaceuticals and Insilico Medicine made our news this week. (Google) Amid a big cancer push, Daiichi Sankyo lured Kite Pharma exec Ken Takeshita to lead its R&D work. China's Clover Biopharmaceuticals secured $230 million in an oversubscribed series C to help advance its COVID-19 vaccine program and expand manufacturing capabilities. In several firsts for artificial-intelligence-based drug discovery, Insilico Medicine discovered a novel target for idiopathic pulmonary fibrosis, designed a new molecule and validated it in preclinical models in 18 months. And more...